AIM: To study the treatment effect of traditional Chinese medicine in the treatment of high myopia macular hemorrhage, using Chinese medicine etiology and pathogenesis, syndrome differentiation treatment, and provide the basis for the clinical treatment.

METHODS: Eighty patients(135 eyes)with high myopia macular hemorrhage were selected in the hospital from January 2012 to september 2014 as treatment group, and applied traditional Chinese medicine treatment. Forty-five patients(64 eyes)with the same period, as the control group, received routine western medicine treatment. After 1mo treatement, the treatment effect and vision improvement situation of two groups were observed, and after 6mo follow-up, the relapse was observed.

RESULTS: The total effective rate of treatment group was 85.19%(115/135), higher than the control group 78.13%(50/64)(P<0.05). The average corrected visual acuity of treatment group was 0.48±0.11, higher than the control group 0.36±0.09, the difference was statistically significant(P<0.05). The average diopter and macular bleeding scope of the treatment group were -9.81±0.85D and 0.51±0.27PD, lower than the control group -10.76±0.91D and 0.78±0.23PD, the differences were statistically significant(P<0.05). The eye ground hemorrhage absorption time of treatment group was 25.34±2.28d, less than the control group 29.72±2.13d, the difference was statistically significant(P<0.05). The bleeding again of the control group 7.81%(5/64), higher than the treatment group was 5.19%(7/135), the difference was statistically significant(P<0.05).

CONCLUSION: Evidence-based treatment of traditional Chinese medicine for high myopia macular hemorrhage has good clinical effect, can shorten the treatment time, and is beneficial to the recovery of postoperative vision, worthy of clinical popularization and application.